These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36776124)

  • 1. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
    Nyame YA; Holt SK; Etzioni RD; Gore JL
    Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy.
    Gooden KM; Howard DL; Carpenter WR; Carson AP; Taylor YJ; Peacock S; Godley PA
    Med Care; 2008 Nov; 46(11):1170-6. PubMed ID: 18953228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.
    Pollack CE; Bekelman JE; Epstein AJ; Liao K; Wong YN; Armstrong K
    Med Care; 2011 Nov; 49(11):999-1006. PubMed ID: 22005606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
    Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
    Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in screening for prostate cancer in the elderly.
    Gilligan T; Wang PS; Levin R; Kantoff PW; Avorn J
    Arch Intern Med; 2004 Sep; 164(17):1858-64. PubMed ID: 15451760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital racial composition and the treatment of localized prostate cancer.
    Pollack CE; Bekelman JE; Liao KJ; Armstrong K
    Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Community-level Disadvantages Account for Racial Disparities in the Safety of Spine Surgery? A Large Database Study Based on Medicare Claims.
    Engler ID; Vasavada KD; Vanneman ME; Schoenfeld AJ; Martin BI
    Clin Orthop Relat Res; 2023 Feb; 481(2):268-278. PubMed ID: 35976183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment.
    Hammarlund N; Holt SK; Basu A; Etzioni R; Morehead D; Lee JR; Wolff EM; Gore JL; Nyame YA
    Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):435-441. PubMed ID: 38214587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer.
    Asiri IM; Chen RC; Young HN; Codling J; Mandawat A; Beach SRH; Master V; Rajbhandari-Thapa J; Cobran EK
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1093-1102. PubMed ID: 33941865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
    Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
    J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
    Wilkins LJ; Tosoian JJ; Reichard CA; Sundi D; Ranasinghe W; Alam R; Schwen Z; Reddy C; Allaf M; Davis JW; Chapin BF; Ross AE; Klein EA; Nyame YA
    Cancer; 2021 May; 127(9):1425-1431. PubMed ID: 33721334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.